Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Data-Oriented, Non-Political Reimbursement In Japan: Wishful Thinking?

This article was originally published in The Gray Sheet

Executive Summary

Despite commitments from the Japanese advisory body Chuikyo, it remains to be seen whether Japan's comparative pricing system for medical devices will reflect reforms sought by U.S. companies, according to Pacific Bridge Medical President Ames Gross

You may also be interested in...



Japan May Seek Pricing Data From Other Asian Markets – MHLW Official

It would be difficult for Japan to extrapolate "meaningful" comparisons from planned device pricing surveys in other Asian markets, while the burden on manufacturers would increase substantially, according to Harold Smith, representative director of consulting firm L.E.K./Acumen Japan

Japan May Seek Pricing Data From Other Asian Markets - MHLW Official

It would be difficult for Japan to extrapolate "meaningful" comparisons from planned device pricing surveys in other Asian markets, while the burden on manufacturers would increase substantially, according to Harold Smith, representative director of consulting firm L.E.K./Acumen Japan

Japan May Seek Pricing Data From Other Asian Markets – MHLW Official

It would be difficult for Japan to extrapolate "meaningful" comparisons from planned device pricing surveys in other Asian markets, while the burden on manufacturers would increase substantially, according to Harold Smith, representative director of consulting firm L.E.K./Acumen Japan

UsernamePublicRestriction

Register

LL035386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel